EVRYSDI (Risdiplam)

**Product type:** Human Prescription Drug

**Active ingredient:** RISDIPLAM

**Strength:** .75 mg/mL

**Dosage form:** Powder, For Solution

**Route:** Oral

**Labeler:** Genentech, Inc.

**Marketing category:** NDA (NDA213535)

**Pharmacologic class:** Increased Protein Synthesis [PE], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Survival of Motor Neuron 2 Splicing Modifier [EPC], Survival of Motor Neuron 2 Splicing Modifiers [MoA]